| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Operating expenses: | ||||||||
Research and development | ||||||||
42,042 | 49,363 | 39,995 | 31,774 | 23,403 | - | 10,870 | 122,486 | - |
General and administrative | ||||||||
15,641 | 15,212 | 15,016 | 14,187 | 13,058 | 14,542 | 11,317 | 12,526 | 2,597 |
Total operating expenses | ||||||||
57,683 | 64,575 | 55,011 | 45,961 | 36,461 | 33,046 | 22,187 | 135,012 | 2,597 |
Loss from operations | ||||||||
-57,683 | -64,575 | -55,011 | -45,961 | -36,461 | -33,046 | -22,187 | -135,012 | -2,597 |
Other income (expense), net: | ||||||||
Change in fair value of convertible note payable | ||||||||
- | - | 0 | - | - | - | 19,415 | - | - |
Interest expense | ||||||||
- | - | 0 | - | - | - | 3,358 | - | - |
Interest and other income, net | ||||||||
3,261 | 3,658 | 4,309 | 4,559 | 4,825 | - | 1,463 | 110 | - |
Other expenses | ||||||||
58 | - | - | - | 0 | - | - | - | - |
Total other income (expense), net | ||||||||
3,203 | - | - | - | 4,825 | - | - | - | - |
Loss before income taxes | ||||||||
-54,480 | -61,185 | -50,702 | -41,402 | -31,636 | -30,626 | -43,497 | -134,902 | -2,597 |
Benefit from income taxes | ||||||||
0 | -105 | 33 | -159 | -100 | - | 0 | 0 | - |
Net loss | ||||||||
-54,480 | -61,030 | -50,735 | -41,243 | -31,586 | -30,509 | -43,497 | -134,902 | -2,597 |
Other comprehensive income: | ||||||||
Net unrealized gain on available-for-sale investments | ||||||||
465 | -721 | -295 | 756 | 1,099 | - | -148 | 0 | - |
Net comprehensive loss | ||||||||
-54,015 | -61,751 | -51,030 | -40,487 | -30,487 | -30,055 | -43,645 | -134,902 | -2,597 |
Net loss per share, basic and diluted (in dollars per share) | ||||||||
-0.50 | -0.60 | -0.50 | -0.41 | -0.32 | 47.32 | -10.71 | -43.82 | -0.10 |
Weighted-average number of shares used in computing net loss per share, basic and diluted (in shares) | ||||||||
108,963 | 104,895 | 102,186 | 99,846 | 97,315 | 82,404 | 4,060 | 3,078 | 26,249 |